Argeris N. Karabelas, Director at REGENXBIO Inc. (RGNX), sold 10,000 shares at $11.50 ($116K) on 2024-09-03, disclosed to the SEC on 2024-09-04.
Scheduled sale ($116k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.50 | 9,300 | $107K | 92.5% |
| 2 | $12.34 | 700 | $9K | 7.5% |
| Total | $11.56 avg | 10,000 | $116K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |
| VRX | BUY | 2016-08-12 | $99K | — | Filing → |